Chinese General Practice ›› 2019, Vol. 22 ›› Issue (31): 3871-3875.DOI: 10.12114/j.issn.1007-9572.2019.00.130
• Monographic Research • Previous Articles Next Articles
Published:
2019-11-05
Online:
2019-11-05
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2019.00.130
[1]代涛,陈瑶,韦潇.医疗卫生服务体系整合:国际视角与中国实践[J].中国卫生政策研究,2012,5(9):1-9.DOI:10.3969/j.issn.1674-2982.2012.09.001. DAI T,CHEN Y,WEI X.Integrated healthcare system:international perspective and Chinese practices[J].Chinese Journal of Health Policy,2012,5(9):1-9.DOI:10.3969/j.issn.1674-2982.2012.09.001. [2]王慧慧.医联体怎样“连体”又“连心”?[N].安徽日报,2015-07-09(05). [3]方鹏骞,林振威,陈诗亮,等.医联体联动模式及其核心医院改革前后综合效益分析:以武汉市为例[J].中国医院,2014,18(7):14-16.DOI:10.3969/j.issn.1671-0592.2014.07.005. FANG P Q,LIN Z W,CHEN S L,et al.Analysis of the linkage mode of medical union and the comprehensive benefits of its core hospital before and after the reform-case of Wuhan[J].Chinese Hospitals,2014,18(7):14-16.DOI:10.3969/j.issn.1671-0592.2014.07.005. [4]医联体建设形成4种成熟模式[EB/OL].(2017-04-14) [2018-12-15]. http://www.scio.gov.cn/32344/32345/35889/36475/zy36479/Document/1548448/1548448.htm. [5]方鹏骞,李曼琪,李文敏.试论三级公立医院在医疗联合体中的引领作用[J].中国医院管理,2018,38(5):1-3. FANG P Q,LI M Q,LI W M.Analysis of the leading role of tertiary public hospitals in medical alliance[J].Chinese Hospital Management,2018,38(5):1-3. [6]邓勇.医院托管:“公公合作”优势何在? [J].中国卫生,2018,34(8):98-99.DOI:10.15973/j.cnki.cn11-3708/d.2018.08.045. DENG Y.Hospital trusteeship:what are the advantages of "public hospital cooperation"? [J].Chinese Health,2018,34(8):98-99.DOI:10.15973/j.cnki.cn11-3708/d.2018.08.045. [7]麻若蒙,方鹏骞.公私合作组建医疗联合体的探讨[J].中国医院管理,2018,38(5):10-12. MA R M,FANG P Q.Exploration of the construction of medical alliance under public and private partnership[J].Chinese Hospital Management,2018,38(5):10-12. [8]江上.医联体:民营医院发展的机遇[J].卫生经济研究,2014,31(4):10-11. JIANG S.Medical association:opportunities for development of private hospitals[J].Health Economics Research,2014,31(4):10-11. [9]任飞.完善区域纵向医联体建设的思考:基于制度理性选择框架[J].中国卫生政策研究,2016,9(10):1-5.DOI:10.3969/j.issn.1674-2982.2016.10.001. REN F.Thoughts on improving the regional longitudinal health consortium:a framework analysis of institutional rational choice[J].Chinese Journal of Health Policy,2016,9(10):1-5.DOI:10.3969/j.issn.1674-2982.2016.10.001. [10]杨曼茹,王志伟,赵桐,等.北京市区域医联体探路分级诊疗的实施困境与对策建议[J].中国医院,2016,20(11):43-45.DOI:10.3969/j.issn.1671-0592.2016.11.012. YANG M R,WANG Z W,ZHAO T,et al.Problems and countermeasures on implementation hierarchical medical treatment by regional medical alliance in Beijing[J].Chinese Hospitals,2016,20(11):43-45.DOI:10.3969/j.issn.1671-0592.2016.11.012. [11]张彦生,王虎峰,刘宪伟,等.自发型医疗联合体运行机制研究:以大连医科大学附属第二医院医疗联盟为例[J].中国医院管理,2018,38(1):17-21. ZHANG Y S,WANG H F,LIU X W,et al.Study on the operating mechanism of spontaneous type medical alliance:a case study of the medical allinace of the second affiliated hospital of Dalian Medical University[J].Chinese Hospital Management,2018,38(1):17-21. [12]梁思园,何莉,宋宿杭,等.我国医疗联合体发展和实践典型分析[J].中国卫生政策研究,2016,9(5):42-48.DOI:10.3969/j.issn.1674-2982.2016.05.008. LIANG S Y,HE L,SONG S H,et al.The development and practice of integrated healthcare in China[J].Chinese Journal of Health Policy,2016,9(5):42-48.DOI:10.3969/j.issn.1674-2982.2016.05.008. [13]黄培,易利华.3种不同类型医联体模式的实践与思考[J].中国医院管理,2015,35(2):16-19. HUANG P,YI L H.Practice and consideration on three types of medical alliance modes[J].Chinese Hospital Management,2015,35(2):16-19. [14]刘婷婷,林琳,夏令国,等.国内区域医疗联合体的研究现况与述评[J].卫生软科学,2016,30(6):5-9.DOI:10.3969/j.issn.1003-2800.2016.06.002. LIU T T,LIN L,XIA L G,et al.Study situation and review of regional medical NACF[J].Soft Science of Health,2016,30(6):5-9.DOI:10.3969/j.issn.1003-2800.2016.06.002. [15]张翔,齐静,高梦阳,等.医疗联合体国内外研究现状及发展动态[J].中国医院管理,2017,37(7):21-24. ZHANG X,QI J,GAO M Y,et al.Research status and development trends of medical unions at home and abroad[J].Chinese Hospital Management,2017,37(7):21-24. [16]陈文华.产业集群治理研究[M].北京:经济管理出版社,2007. [17]周新燕,戴文娟.价值链管理在医联体经济运营中的应用探索[J].中国卫生经济,2018,37(2):80-82.DOI:10.7664/CHE20180222. ZHOU X Y,DAI W J.Exploring the application of value chain management in the operation of medical conjoined economy[J].Chinese Health Economics,2018,37(2):80-82.DOI:10.7664/CHE20180222. [18]孙渤星,张瑞华,陈瑜,等.我国现行医疗联合体的发展与挑战[J].医学与哲学,2015,36(7):45-46. SUN B X,ZHANG R H,CHEN Y,et al.Development and challenges of current medical consortium in China[J].Medicine & Philosophy,2015,36(7):45-46. [19]吕剑楠,王芳,田淼淼,等.江苏省常州市区域医疗机构服务协同案例分析[J].中国卫生政策研究,2017,10(4):37-41.DOI:10.3969/j.issn.1674-2982.2017.04.007. LYU J N,WANG F,TIAN M M,et al.Analysis of synergistic service of health institutions:a case study of Changzhou City in Jiangsu Province[J].Chinese Journal of Health Policy,2017,10(4):37-41.DOI:10.3969/j.issn.1674-2982.2017.04.007. [20]汪彬,宓轶群,李娜,等.分级诊疗制度下医疗联合体绩效评价体系初步探索[J].中国医院,2017,21(5):3-5.DOI:10.3969/j.issn.1671-0592.2017.05.002. WANG B,MI Y Q,LI N,et al.Discussion on healthcare alliance performance assessment system under hierarchical healthcare system[J].Chinese Hospitals,2017,21(5):3-5.DOI:10.3969/j.issn.1671-0592.2017.05.002. [21]龙俊睿,孙自学,段光锋,等.PLS-BP神经网络模型应用于医联体绩效评估的可行性分析[J].中国医院管理,2018,38(6):58-60. LONG J R,SUN Z X,DUAN G F,et al.Analysis of feasibility in using PLS-BP neural network model to assess the performance evaluation of medical alliance[J].Chinese Hospital Management,2018,38(6):58-60. [22]李曼琪,李文敏,方鹏骞.我国医疗联合体法人治理的可行性分析及路径选择[J].中国医院管理,2018,38(5):7-9. LI M Q,LI W M,FANG P Q.Feasibility analysis and path choice of the corporate governance of medical alliance in China[J].Chinese Hospital Management,2018,38(5):7-9. [23]陈静,夏述旭.紧密型医疗联合体人力资源配置与共享关键问题分析[J].中国医院管理,2018,38(2):50-52. CHEN J,XIA S X.Analysis of key issues of human resource allocation and sharing in close medical alliance[J].Chinese Hospital Management,2018,38(2):50-52. [24]王以坤,李少冬,任泽强,等.分级诊疗制度在紧密型医疗联合体中实施情况分析[J].中国医院管理,2018,38(8):8-10. WANG Y K,LI S D,REN Z Q,et al.Analysis of the implementation of hierarchical diagnosis and treatment system in compact medical alliance[J].Chinese Hospital Management,2018,38(8):8-10. [25]肖立新,张志军,刘继霞,等.“医联体模式下二级医院与社区卫生服务机构工作模式”主题研讨[J].中国全科医学,2014,17(34):4027-4032.DOI:10.3969/j.issn.1007-9572.2014.34.001. XIAO L X,ZHANG Z J,LIU J X,et al.Theme discussion on the working modes of secondary hospitals and community health service organizations under the mode of medical association[J].Chinese General Practice,2014,17(34):4027-4032.DOI:10.3969/j.issn.1007-9572.2014.34.001. [26]任苒.对医联体建设发展定位的思考[J].医学与哲学,2018,39(11):6-11.DOI:10.12014/j.issn.1002-0772.2018.06a.02. REN R.Thoughts on the orientation of development and construction for regional medical care unions[J].Medicine & Philosophy,2018,39(11):6-11.DOI:10.12014/j.issn.1002-0772.2018.06a.02. [27]山西省卫生计生委.山西:下活健康服务“一盘棋”[EB/OL].(2018-09-03) [2018-10-06].http://www.jkb.com.cn/management/2018/0903/437313.html. [28]GOES J,SAVAGE G T,FRIEDMAN L.The evolution of integrated health care strategies[M].London:Emerald Group Publishing Limited,2000. [29]王峻彦.基于医联体的社区“四站式”康复服务模式探讨[J].中国全科医学,2018,21(5):555-558.DOI:10.3969/j.issn.1007-9572.2018.05.012. WANG J Y."Four stops" rehabilitation service mode based on the medical union[J].Chinese General Practice,2018,21(5):555-558.DOI:10.3969/j.issn.1007-9572.2018.05.012. [30]高晓燕,辛文琳,康敏,等.医联体内知识共享的互动形式及保障机制研究[J].中国全科医学,2018,21(13):1546-1549.DOI:10.3969/j.issn.1007-9572.2018.13.007. GAO X Y,XIN W L,KANG M,et al.Interactive forms and support mechanisms for knowledge sharing in a medical consortium[J].Chinese General Practice,2018,21(13):1546-1549.DOI:10.3969/j.issn.1007-9572.2018.13.007. [31]孙涛,张薇,葛思澳,等.区域医疗联合体的联盟稳定性评价指标体系框架[J].中国医院管理,2016,36(4):5-7. SUN T,ZHANG W,GE S A,et al.A framework of evaluation index system of medical alliance stability for the regional integrated care organizations[J].Chinese Hospital Management,2016,36(4):5-7. [32]张瑞华,赵大仁,何思长,等.我国医联体实践的问题探析与思考[J].卫生经济研究,2016,33(6):12-15.DOI:10.14055/j.cnki.33-1056/f.20160606.017. ZHANG R H,ZHAO D R,HE S Z,et al.Analysis and reflection on the practice of medical union practice in China[J].Health Economics Research,2016,33(6):12-15.DOI:10.14055/j.cnki.33-1056/f.20160606.017. [33]沈媛巧.医联体建设风潮将至 哪种模式最值得期待[EB/OL].(2017-03-08)[2018-12-15].https://www.cn-healthcare.com/article/20170308/content-490337.html. |
[1] | LI Kexin,LYU Jing,YU Bing,LUO Haoming. Emerging Markers of Frailty in Older People: Recent Strides and Prospect [J]. Chinese General Practice, 2021, 24(36): 4580-4586. |
[2] | REN Siqiang, ZHANG Qian, DAI Yuxi, ZHEN Xicheng. Latest Developments in Physical Fatigue Evaluation Methods in Patients with Stroke [J]. Chinese General Practice, 2021, 24(36): 4661-4664. |
[3] | SUN Jian, MAO Xingxing, LONG Yuanyuan, SHA Mengqi, LIU Xiping, CHEN Yan, HUANG Pei. Research Progresses on the Role of Glucose-6-phosphate Dehydrogenase in Tumors [J]. Chinese General Practice, 2021, 24(35): 4540-4548. |
[4] | HE Chunhua,WANG Jinfang,WANG Qingguo. Latest Advances in Cardiovascular Risk in Primary Hyperparathyroidism [J]. Chinese General Practice, 2021, 24(33): 4287-4292. |
[5] | WANG Yucheng,CHEN Zhiwei,CHEN Ruizhen. Clinical Characteristics and Comprehensive Management of Heart Failure with Improved Ejection Fraction [J]. Chinese General Practice, 2021, 24(32): 4049-4054. |
[6] | GAO Tianli. Imaging Evaluation of Vulnerable Carotid Plaques:Present Status and Future Prospect [J]. Chinese General Practice, 2021, 24(32): 4055-4060. |
[7] | WANG Xue,ZHOU Yuqiu,LIU Dongwei,WANG Weiliang,MENG Xiangyu,ZHANG Chunyu. Recent Advances in Cognitive Impairment in Schizophrenia:Stage-specific Features and Interventions [J]. Chinese General Practice, 2021, 24(32): 4121-4125. |
[8] | ZHU Lingyan,SHEN Yi,SHAO Yi,LIU Fen. The Role of m6A RNA Methylation Modification in Esophageal Cancer [J]. Chinese General Practice, 2021, 24(32): 4150-4154. |
[9] | ZHOU Lulu,LU Yuan,LIU Yalin,ZHANG Hui,YU Dehua,TANG Lan. Recent Advances in Non-pharmacological Treatment of Mild Cognitive Impairment [J]. Chinese General Practice, 2021, 24(31): 4027-4031. |
[10] | WANG Jianan,LIU Lamei,SUN Mengjie. Recent Progress on Transitional Care Assessment Tools for Older Chronic Disease Patients [J]. Chinese General Practice, 2021, 24(31): 4032-4036. |
[11] | FAN Ziyu,FANG Xuan,ZHANG Sheng. Invasive Lobular Carcinoma of Breast:Clinicopathological Features,Current and Prospective Diagnosis and Treatment [J]. Chinese General Practice, 2021, 24(30): 3806-3813. |
[12] | YANG Rong,LIAO Xiaoyang,LEI Yi,YUAN Mengyi. Advances in the Key Oncogene and Tumor-suppressor Gene in Early Lung Adenocarcinoma [J]. Chinese General Practice, 2021, 24(29): 3774-3780. |
[13] | QIN Yao,ZHANG Jiajia,WU Yan,GE Xiaoyan,HAN Hongjuan,CUI Jing,BAI Wenlin,YU Hongmei. Research Progress on Reversion of Mild Cognitive Impairment to Normal Cognition [J]. Chinese General Practice, 2021, 24(27): 3506-3509. |
[14] | HAN Jiaqi,WANG Wei. Classification and Clinical Characteristics of Adulthood Leukoencephalopathies [J]. Chinese General Practice, 2021, 24(27): 3510-3517. |
[15] | ZHAO Minjun,LI Shuangqing. Latest Advances in Mechanisms of Non-pharmacological Interventions to Improve Multiple Chronic Conditions [J]. Chinese General Practice, 2021, 24(26): 3369-3376. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||